Novel Dual Domain Targeting Strategies against ErbB Receptors [ 2015 - ]

Research Grant

Researchers: Prof Andrew Scott (Principal investigator) ,  A/Pr Andrew Clayton ,  A/Pr Hui Gan ,  Dr Nathalie Dhomen ,  Prof Daniel Leahy

Brief description This project will develop innovative strategies to treat cancer through novel antibodies to erbB growth factor receptors, and identify ways to improve conventional treatments.

Funding Amount $688,813.00

Funding Scheme Project Grants

Notes Standard Project Grant